152 related articles for article (PubMed ID: 24329118)
21. Clinical toxicology of newer recreational drugs.
Hill SL; Thomas SH
Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
[TBL] [Abstract][Full Text] [Related]
22. Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis.
Palma-Conesa ÁJ; Ventura M; Galindo L; Fonseca F; Grifell M; Quintana P; Fornís I; Gil C; Farré M; Torrens M
J Psychoactive Drugs; 2017; 49(4):297-305. PubMed ID: 28569652
[TBL] [Abstract][Full Text] [Related]
23. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
Gatch MB; Dolan SB; Forster MJ
Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
[TBL] [Abstract][Full Text] [Related]
24. Combined intoxication with methylone and 5-MeO-MIPT.
Shimizu E; Watanabe H; Kojima T; Hagiwara H; Fujisaki M; Miyatake R; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):288-91. PubMed ID: 16876302
[TBL] [Abstract][Full Text] [Related]
25. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.
Bassi M; Bilel S; Tirri M; Corli G; Di Rosa F; Gregori A; Alkilany AM; Rachid O; Roda E; Zauli G; Locatelli CA; Marti M
Psychopharmacology (Berl); 2024 Mar; 241(3):489-511. PubMed ID: 38214743
[TBL] [Abstract][Full Text] [Related]
26. Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae).
Schwelm HM; Zimmermann N; Scholl T; Penner J; Autret A; Auwärter V; Neukamm MA
J Anal Toxicol; 2022 May; 46(5):540-548. PubMed ID: 33851996
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology and Literature Review Based on Related Death and Non-Fatal Case Reports of the Benzofurans and Benzodifurans Designer Drugs.
Barcelo B; Gomila I
Curr Pharm Des; 2017; 23(36):5523-5529. PubMed ID: 28714411
[TBL] [Abstract][Full Text] [Related]
28. Trends in DMT and other tryptamine use among young adults in the United States.
Palamar JJ; Le A
Am J Addict; 2018 Oct; 27(7):578-585. PubMed ID: 30260086
[TBL] [Abstract][Full Text] [Related]
29. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
30. Intoxication delirium following use of synthetic cathinone derivatives.
Penders TM; Gestring RE; Vilensky DA
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):616-7. PubMed ID: 22783894
[TBL] [Abstract][Full Text] [Related]
31. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
Bäckberg M; Beck O; Helander A
Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
[TBL] [Abstract][Full Text] [Related]
32. Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.
Fabregat-Safont D; Barneo-Muñoz M; Martinez-Garcia F; Sancho JV; Hernández F; Ibáñez M
J Chromatogr A; 2017 Jul; 1508():95-105. PubMed ID: 28602505
[TBL] [Abstract][Full Text] [Related]
33. Acute confusional state after designer tryptamine abuse.
Itokawa M; Iwata K; Takahashi M; Sugihara G; Sasaki T; Abe Y; Uno M; Hobo M; Jitoku D; Inoue K; Arai M; Yasuda I; Shintani M
Psychiatry Clin Neurosci; 2007 Apr; 61(2):196-9. PubMed ID: 17362440
[TBL] [Abstract][Full Text] [Related]
34. "Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use.
Kasick DP; McKnight CA; Klisovic E
Am J Drug Alcohol Abuse; 2012 Mar; 38(2):176-80. PubMed ID: 22221190
[TBL] [Abstract][Full Text] [Related]
35. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
Gibbons S
Clin Toxicol (Phila); 2012 Jan; 50(1):15-24. PubMed ID: 22248120
[TBL] [Abstract][Full Text] [Related]
36. Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
Lancelotta RL; Davis AK
J Psychoactive Drugs; 2020; 52(3):273-281. PubMed ID: 32148190
[TBL] [Abstract][Full Text] [Related]
37. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'.
Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
Ann Agric Environ Med; 2012; 19(4):871-82. PubMed ID: 23311821
[TBL] [Abstract][Full Text] [Related]
38. Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances.
Byard RW; Cox M; Stockham P
J Forensic Sci; 2016 Nov; 61(6):1546-1548. PubMed ID: 27723094
[TBL] [Abstract][Full Text] [Related]
39. The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
Davis AK; Barsuglia JP; Lancelotta R; Grant RM; Renn E
J Psychopharmacol; 2018 Jul; 32(7):779-792. PubMed ID: 29708042
[TBL] [Abstract][Full Text] [Related]
40. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
Shulgin AT; Carter MF
Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
